Mannitol Contraindications and Precautions

Critical Clinical Situations Requiring Extreme Caution

The KDOQI Work Group states that osmotic diuretics like mannitol may only potentially benefit patients with creatine kinase levels >30,000 U/L, but this benefit remains undefined and mannitol should be administered with extreme caution and is specifically contraindicated in oligoanuric patients 1
Loop diuretics or mannitol should not be used in patients with concomitant obstructive uropathy or hypovolemia when treating tumor lysis syndrome 2

The American Heart Association explicitly advises against using furosemide, mannitol, or dopamine solely for the purpose of renal protection in descending aortic repairs, as these agents have not been demonstrated to provide renal protection during such procedures 3
The American Heart Association's guideline is supported by other clinical guidelines, which also recommend against using mannitol for renal protection in high-risk populations 4

The American Journal of Kidney Diseases recommends avoiding the use of mannitol in hemodialysis patients for volume management, instead preferring appropriate ultrafiltration techniques and dietary sodium restriction, as mannitol causes significant fluid and electrolyte imbalances, particularly hypernatremia, in patients with impaired renal function 4
In rhabdomyolysis, diuresis should only be considered after adequate volume expansion has been achieved, and mannitol should be used with caution 1

The KDIGO guidelines explicitly state that pharmacologic manipulations, including mannitol, have shown inconclusive results for preventing ischemic kidney injury, and therefore mannitol should not be routinely administered during partial nephrectomy 5, 6
The KDIGO Controversies Conference on Onco-Nephrology (2020) states that results of most translational studies on mannitol use during partial nephrectomy remain inconclusive, and studies to date have been negative 5, 6

The KDIGO guidelines recommend focusing on proven intraoperative maneuvers for preventing irreversible ischemic injury, including minimizing ischemia time, using hypothermia when appropriate, early unclamping techniques, zero ischemia techniques when feasible, and minimizing nephron loss through precise surgical technique 5, 6
Minimize ischemia time (keep warm ischemia <25-30 minutes) 5
Use hypothermia when appropriate 6
Use early unclamping techniques 6
Use zero ischemia techniques when feasible 6
Minimize nephron loss through precise surgical technique 6